Literature DB >> 24989038

Evaluation of sedation and clinical effects of midazolam with ketamine or dexmedetomidine in pet rabbits.

L Bellini1, T Banzato1, B Contiero1, A Zotti1.   

Abstract

The effects of two sedation protocols combining midazolam with ketamine (ketamine group) or dexmedetomidine (dexmedetomidine group) were studied in dwarf companion rabbits undergoing abdominal ultrasound scan. The onset of sedation was faster in the ketamine group; a few rabbits in the dexmedetomidine group required additional doses to lose the righting reflex, although sedation time was not different between groups. A semi-quantitative scale was used to score sedation quality, which was higher in rabbits that received dexmedetomidine rather than ketamine. Pulse rate was lower in the dexmedetomidine group (206 vs 240 bpm), although Doppler blood pressure was higher than in the ketamine group (109 vs 89 mm Hg). Respiratory rate decreased in relation to the baseline values with both protocols but arterial haemoglobin saturation with oxygen was maintained similar to the pre-sedation values throughout the entire procedure, regardless of protocol used and without oxygen supplementation. Both protocols allowed performance of ultrasound scanning, although dexmedetomidine may be preferred if a deep sedation level is required. British Veterinary Association.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24989038     DOI: 10.1136/vr.102595

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  2 in total

1.  Intramuscular Alfaxalone-Butorphanol-Midazolam Compared with Ketamine-Butorphanol- Midazolam in New Zealand White Rabbits.

Authors:  Kyra A Knutson; Olivia A Petritz; Andrea E Thomson; Julie A Balko
Journal:  J Am Assoc Lab Anim Sci       Date:  2022-08-26       Impact factor: 1.706

2.  Prospective clinical study to evaluate an oscillometric blood pressure monitor in pet rabbits.

Authors:  Luca Bellini; Irene A Veladiano; Magdalena Schrank; Matteo Candaten; Antonio Mollo
Journal:  BMC Vet Res       Date:  2018-02-27       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.